Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 82009-177

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 82009-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin10mg1000slabel (Atorvastatin10mg1000slabel)

Label for Atorvastatin Calcium Tablets, USP 10 mg by Quallent Pharmaceuticals Health LLC. The film-coated tablets come in a package of 1000. The label includes storage instructions, U.S. contact information, and manufacturing details by Annora Pharma Pvt. Ltd., Telangana, India, with labeling for Rx only.*

FDA Label Image

Atorvastatin20mg1000slabel (Atorvastatin20mg1000slabel)

Label for Atorvastatin Calcium Tablets, USP 20 mg film-coated tablets by Quallent Pharmaceuticals Health LLC. The label includes storage instructions, dosage guidance referencing package insert, a barcode, and manufacturer details Annora Pharma Pvt. Ltd., India. Package size is 1000 tablets with NDC 82009-177-10.*

FDA Label Image

Atorvastatin40mg1000slabel (Atorvastatin40mg1000slabel)

Label for Atorvastatin Calcium Tablets, USP 40 mg, film-coated oral tablets, manufactured for Quallent Pharmaceuticals Health LLC. The label includes dosage instructions, storage conditions, a barcode, contact number, and manufacturing details by Annora Pharma Pvt. Ltd., India. Package size is 1000 tablets.*

FDA Label Image

Atorvastatin80mg1000slabel (Atorvastatin80mg1000slabel)

Label for Atorvastatin Calcium Tablets, USP 80 mg film-coated oral tablets. The label indicates a package containing 1000 tablets, manufactured for Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands, by Annora Pharma Pvt. Ltd., India. Storage instructions and dispensing information are also included.*

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

A line graph comparing cumulative incidence percentages over approximately 3.5 years, showing two curves for Atorvastatin and placebo. The Atorvastatin curve has a lower cumulative incidence compared to placebo, with reported hazard ratio (HR = 0.64), confidence interval (0.50-0.83), and p-value (0.0005) at the bottom right.*

FDA Label Image

Atorvastatinfigure2 (Atorvastatinfigure2)

A Kaplan-Meier cumulative hazard curve comparing Atorvastatin versus placebo over five years. The x-axis represents time to the first primary endpoint over four years of follow-up, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio (HR 0.63 with confidence interval 0.48-0.83) and a p-value of 0.001.*

FDA Label Image

Atorvastatinfigure3 (Atorvastatinfigure3)

A line graph illustrating the proportion of subjects experiencing events over a 5-year period. The graph compares Atorvastatin 10 mg and 80 mg doses, with the x-axis labeled as time to first major cardiovascular endpoint in years, and the y-axis showing the percentage of subjects experiencing events. Hazard ratio and p-value are noted on the chart.*

FDA Label Image

Atorvastatinstructure (Atorvastatinstructure)

Chemical structure diagram of atorvastatin calcium, showing its molecular components including aromatic rings, fluorine substitution, and calcium salt complex with water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.